blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1891002

EP1891002 - CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.04.2013
Database last updated on 02.11.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Merck Sharp & Dohme Limited
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
[2008/09]
Inventor(s)01 / BLACKABY, Wesley Peter@Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow Essex CM20 2QR / GB
02 / CASTRO PINEIRO, Jose Luis@Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow Essex CM20 2QR / GB
03 / LEWIS, Richard Thomas@Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow Essex CM20 2QR / GB
04 / NAYLOR, Elizabeth Mary@Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow Essex CM20 2QR / GB
05 / STREET, Leslie Joseph@Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow Essex CM20 2QR / GB
 [2012/22]
Former [2008/09]01 / BLACKABY, Wesley Peter Merck & Co., Inc.
Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
02 / CASTRO PINEIRO, Jose Luis Merck & Co., Inc.
Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
03 / LEWIS, Richard Thomas Merck & Co., Inc.
Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
04 / NAYLOR, Elizabeth Mary Merck & Co., Inc.
Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
05 / STREET, Leslie Joseph Merck & Co., Inc.
Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2012/22]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Merck Sharpe & Dohme Limited Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2008/09]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Application number, filing date06744106.305.06.2006
[2008/09]
WO2006GB02052
Priority number, dateGB2005001145206.06.2005         Original published format: GB 0511452
GB2005001678717.08.2005         Original published format: GB 0516787
GB2005002496808.12.2005         Original published format: GB 0524968
[2008/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006131713
Date:14.12.2006
Language:EN
[2006/50]
Type: A1 Application with search report 
No.:EP1891002
Date:27.02.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 14.12.2006 takes the place of the publication of the European patent application.
[2008/09]
Type: B1 Patent specification 
No.:EP1891002
Date:30.05.2012
Language:EN
[2012/22]
Search report(s)International search report - published on:EP14.12.2006
ClassificationIPC:C07C317/30, C07D249/04, A61K31/166, A61K31/4192, A61P25/18
[2008/09]
CPC:
C07D213/82 (EP,US); A61P25/18 (EP); A61P43/00 (EP);
C07C233/70 (EP,US); C07C233/76 (EP,US); C07C317/30 (EP,US);
C07D231/12 (EP,US); C07D231/18 (EP,US); C07D239/28 (EP,US);
C07D249/04 (EP,US); C07D285/125 (EP,US); C07D295/108 (EP,US);
C07D295/135 (EP,US); C07D307/68 (EP,US); C07D333/38 (EP,US);
C07D471/04 (EP,US); C07D495/04 (EP,US); C07C2601/02 (EP,US);
C07C2601/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/09]
Extension statesHR07.01.2008
TitleGerman:CYCLOHEXANSULFONYL-DERIVATE ALS GLYT1-HEMMER ZUR BEHANDLUNG VON SCHIZOPHRENIE[2008/09]
English:CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA[2008/09]
French:DÉRIVÉS DE CYCLOHEXANESULFONYLE EN TANT QU INHIBITEURS DE GLYT1 POUR TRAITER LA SCHIZOPHRÉNIE[2008/09]
Entry into regional phase07.01.2008National basic fee paid 
07.01.2008Designation fee(s) paid 
07.01.2008Examination fee paid 
Examination procedure07.01.2008Examination requested  [2008/09]
06.08.2008Despatch of a communication from the examining division (Time limit: M04)
14.08.2008Reply to a communication from the examining division
14.12.2011Communication of intention to grant the patent
16.04.2012Fee for grant paid
16.04.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.08.2008
Opposition(s)01.03.2013No opposition filed within time limit [2013/19]
Fees paidRenewal fee
30.06.2008Renewal fee patent year 03
30.06.2009Renewal fee patent year 04
30.06.2010Renewal fee patent year 05
07.06.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.06.2006
AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
TR30.05.2012
IE05.06.2012
LU05.06.2012
MC30.06.2012
BG30.08.2012
GR31.08.2012
ES10.09.2012
IS30.09.2012
PT01.10.2012
[2014/34]
Former [2014/27]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
TR30.05.2012
IE05.06.2012
LU05.06.2012
MC30.06.2012
BG30.08.2012
GR31.08.2012
ES10.09.2012
IS30.09.2012
PT01.10.2012
Former [2014/21]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
TR30.05.2012
IE05.06.2012
MC30.06.2012
BG30.08.2012
GR31.08.2012
ES10.09.2012
IS30.09.2012
PT01.10.2012
Former [2013/34]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
IE05.06.2012
MC30.06.2012
BG30.08.2012
GR31.08.2012
ES10.09.2012
IS30.09.2012
PT01.10.2012
Former [2013/22]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
IE05.06.2012
MC30.06.2012
GR31.08.2012
ES10.09.2012
IS30.09.2012
PT01.10.2012
Former [2013/20]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
IE05.06.2012
MC30.06.2012
GR31.08.2012
IS30.09.2012
PT01.10.2012
Former [2013/13]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
MC30.06.2012
GR31.08.2012
IS30.09.2012
PT01.10.2012
Former [2013/11]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
IT30.05.2012
LT30.05.2012
LV30.05.2012
PL30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
MC30.06.2012
GR31.08.2012
IS30.09.2012
Former [2013/10]AT30.05.2012
BE30.05.2012
CY30.05.2012
CZ30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
RO30.05.2012
SE30.05.2012
SI30.05.2012
SK30.05.2012
MC30.06.2012
GR31.08.2012
IS30.09.2012
Former [2013/09]AT30.05.2012
BE30.05.2012
CY30.05.2012
DK30.05.2012
EE30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
SE30.05.2012
SI30.05.2012
MC30.06.2012
GR31.08.2012
IS30.09.2012
Former [2013/08]AT30.05.2012
BE30.05.2012
CY30.05.2012
DK30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
SE30.05.2012
SI30.05.2012
MC30.06.2012
GR31.08.2012
IS30.09.2012
Former [2013/07]AT30.05.2012
BE30.05.2012
CY30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
SE30.05.2012
SI30.05.2012
GR31.08.2012
IS30.09.2012
Former [2013/04]BE30.05.2012
CY30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
SE30.05.2012
SI30.05.2012
GR31.08.2012
IS30.09.2012
Former [2012/51]CY30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
SE30.05.2012
SI30.05.2012
GR31.08.2012
IS30.09.2012
Former [2012/50]CY30.05.2012
FI30.05.2012
LT30.05.2012
LV30.05.2012
SE30.05.2012
GR31.08.2012
IS30.09.2012
Former [2012/49]CY30.05.2012
FI30.05.2012
LT30.05.2012
SE30.05.2012
IS30.09.2012
Former [2012/48]FI30.05.2012
LT30.05.2012
SE30.05.2012
Former [2012/47]LT30.05.2012
Cited inInternational search[A]WO2005046601  (MERCK & CO INC [US], et al) [A] 1-15 * the whole document *;
 [A]FR2861073  (SANOFI SYNTHELABO [FR]) [A] 1-15 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.